A single series of intrarectal botulinum toxin type A injections may provide significant improvement in fecal incontinence symptoms. Submucosal intrarectal injections of botulinum toxin type A (BoNTA) ...

SAN FRANCISCO—Slightly more than half of patients with refractory idiopathic detrusor overactivity (IDO) incontinence have complete restoration of continence one month after intradetrusor injections ...

Source: Getty Images Long-term post-prostatectomy urinary incontinence affects 3% to 10% of patients. Intravesical botulinum toxin treatment for post-prostatectomy overactive bladder (OAB) appears ...

Injection of botulinum toxin type A into the detrusor smooth muscle is a minimally invasive treatment for incontinence related to neurogenic detrusor overactivity; re-injection is usually necessary ...

Overactive bladder affects an estimated 33 million adults in the United States and is characterized by urinary urgency, ...

Botox, the flagship drug of Irvine-based Allergan Inc., may help treat some overactive bladder conditions, according to a study released Tuesday. Allergan paid for the study, which was run by Dr.

Trial Did Not Meet Primary Endpoint Believed to be the Result of BOTOX Not Effectively Permeating the Urothelium RTGel Delivered Treatment to the Bladder as Expected with Dwell Time of Up to 10 Hours ...